Stamford, CT -- (SBWIRE) -- 01/29/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Tranzbyte Corp (OTCMKTS:ERBB), Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN), Exelixis, Inc. (NASDAQ:EXEL), United States Steel Corporation (NYSE:X).
Tranzbyte Corp (OTCMKTS:ERBB) opened its last trade at the price of $0.02. Its closing price was $0.0190 after gaining 31.03% for the day. The company traded with the total volume of 328.83 million shares, while its average trading volume remained 182.14 million shares. The beta of this stock stands at 7.61. Tranzbyte Corporation operates medical marijuana retail dispensaries under the Altitude Organic Medicine brand name in California, Colorado, and Arizona. The company also produces a portfolio of RFID readers, tags, sensor tags, sensor probes, and RFID-enabled data logging tags.
For How Long ERBB will Fight for Profitability? Read This Trend Analysis report
Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) percentage change plunged -2.40% to close at $0.996 with the total traded volume of 5.06 million shares, along with average volume of 12.67 million shares. The 52 week range of the stock remained $0.28 - $1.85, while its day lowest price was $0.98. The share price hit the day highest price of $1.02. Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of treatments for cancer, central nervous system disorders, sexual dysfunction, and other medical needs.
Has RNN Found The Bottom And Ready To Gain Momentum? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) traded on volume of 8.43 million shares in the last session against average volume of 3.31 million shares. The company started its trading session with the price of $6.93 and closed at $6.96 by scoring -1.97%. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
Why Should Investors Buy EXEL After the Recent Fall? Just Go Here and Find Out
United States Steel Corporation (NYSE:X) started its last trading session with the price of $26.10 and closed at $25.34 by scoring -0.43%. The stock traded with total volume of 17.84 million shares, while the average trading volume remained 6.94 million shares. The beta value of this stock stands at 2.28. Day range for the stock was $24.71 - $26.41. United States Steel Corporation produces and sells steel mill products in North America and Europe. The company operates in three segments: Flat-Rolled Products (Flat-Rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular).
Will X Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)